Internet Diabetes Self-Management Workshop

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Kate Lorig, Stanford University
ClinicalTrials.gov Identifier:
NCT00185601
First received: September 9, 2005
Last updated: April 18, 2013
Last verified: April 2013
  Purpose

The purpose of this study is to determine of the effectiveness of an Internet based Diabetes Self-Management workshop for people with type II diabetes. Half of the people who complete the workshop will be invited to continue their education by participating in a email discussion group. Thus, we will be able to learn both the efficacy of the original program as well as its efficacy when reinforced by the discussion group.

Diabetes is a disease that must be managed day by day by the individual with the disease. Although we know a great deal about the self-management of type II diabetes, most self-management is less than optimal. In addition, most people with diabetes do not have an opportunity to participate in formal diabetes education. This study will determine if an Internet delivered educational workshop will help people with diabetes manage their disease. Thus we will be measuring changes in behaviors, changes in symptoms and changes in HbA1c, blood pressure, cholesterol, and weight. If successful the workshop will serve as a prototype for Internet diabetes education.


Condition Intervention
Diabetes Mellitus, Type 2
Behavioral: Internet Diabetes Self-Management Program

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Internet Diabetes Self-Management Evaluation

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • HbA1c [ Time Frame: 6 and 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Outcome Measure: Health-related quality of life [ Time Frame: 6 and 12 months ] [ Designated as safety issue: No ]
  • Outcome Measure: Health behaviors [ Time Frame: 6 and 12 months ] [ Designated as safety issue: No ]
  • Health care utilization [ Time Frame: 6 and 12 months ] [ Designated as safety issue: No ]

Enrollment: 761
Study Start Date: February 2006
Study Completion Date: June 2010
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
on-line self management intervention Behavioral: Internet Diabetes Self-Management Program
No Intervention: usual care control group
Experimental: on-line self management intervention with email reinforcement Behavioral: Internet Diabetes Self-Management Program

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria::- Diabetes type 2

  • Have internet access and email address
  • Live in the United States
  • 18 years of age or older

Exclusion Criteria:- Previous participation in similar online or community-based self-management program

  • Active treatment for cancer
  • Pregnant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00185601

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Kate R Lorig Stanford University
  More Information

Additional Information:
No publications provided by Stanford University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kate Lorig, professor emertius, Stanford University
ClinicalTrials.gov Identifier: NCT00185601     History of Changes
Other Study ID Numbers: 5 R18 DK065729-02
Study First Received: September 9, 2005
Last Updated: April 18, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on September 16, 2014